{"entity":{"id":"nct07149363","kind":"trial","name":"Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer","aka":[],"tldr":"A phase 2 trial in lung cancer, run by Alliance Foundation Trials, LLC., now recruiting.","summary":"Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer is a phase 2, interventional study registered as NCT07149363 by Alliance Foundation Trials, LLC., with a registry enrolment figure of 65 participants, started 2026-02-12 and due to reach its primary completion in 2029-02. Interventions recorded: Durvalumab 50 MG/ML. Conditions listed: Small Cell Lung Cancer (SCLC). Primary outcome: Disease free survival (DFS). Lung eligibility wording from the registry: \"* Must have histologically or cytologically confirmed diagnosis of pathologic T1-T2 N0-1 M0 small-cell lung cancer per the American Joint Committee on Cancer staging system, 8th edition\". Sites: United States. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT07149363","url":"https://clinicaltrials.gov/study/NCT07149363"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["sclc"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":["astrazeneca"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07149363","phase":"2","setting":"Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer","sponsor":"Alliance Foundation Trials, LLC.","enrolled":65,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07149363/","neighbours":{"cancer":[{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"company":[{"id":"astrazeneca","kind":"company","name":"AstraZeneca","route":"/companies/astrazeneca/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}